Immodulon Therapeutics

Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer. Its drug candidate IMM-101 is applicable to a range of cancers. The company provides treatments for advanced melanoma, skin cancer, and for advanced pancreatic cancer.